Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Dr A
Perhaps there was not room for both of them, and a man at 2 days a week comes cheaper than a full timer. Presumably they had worked together on PHE. One can only speculate on their ability to work together. Perhaps DR was more of a straight research engineer and the new guy has more experience of getting projects to market
I agree that DR, who has done a huge amount for PHE, seems to be being being pushed out. Whether it is as a result of disagreements with Yeo, I do not know, but I certainly know who I would get rid of if it was a straight choice.
Complementary if anything at all. It is more of a screening test, rather than a tool for the management of established disease. I do not know how sensitive the test mentioned is. It will not get in the way of Parsortix, for sure.
AFC must be absolutely certain that the orders are about to roll if they are recruiting ~40 more staff on both sales and engineering sides this year. This makes me feel very confident for AFC during hte rest of 2021.
Andym/gkb
Sadly, the party won't dump our fragrant and elegant PM, because, strange to tell, he somehow does it for a large enough section of the population. The sooner he returns to his original profession as a hack, the better for all of us. And the Daily Telegraph is welcome to him.
One matter of concern shouild be how well the Parsortix system is patented. Here is a reference to a paper out of China describing a Parsortix like device manufactured in a lab. There may be others who are working on systems using a similar device that may work around the Parsortix patent and spoil the party. I will try to obtain the abstract at least.
Jin X, Chen R, Zhao S, Li P, Xue B, Chen X, Zhu X. Biomed Microdevices. 2018 Jun 20;20(2):51. doi: 10.1007/s10544-018-0293-5. PMID: 29926198
In this article, an attempt for efficient screening of circulating tumor cells (CTCs) with excellent operability on microfluidic chips was reported. A Parsortix-like cell separation chip was manufactured in our lab. This chip allowed lateral flow of fluid which increased t …
Gerkin
I agree. These positive RNS come thick and fast, and no longer have much impact on SP. I wonder if one of the big pharma firms have already considered a buy out, but as AGL has tie ups with more than one of the big boys - Abbott for one - I doubt if the existence of Parsortix has escaped attention. We are in for a wonderful ride, dv.
Cheddars
This is a tough call for Airbus. Hydrogen is very leaky- being a small molecule it gets through tiny spaces. It alters the properties of some steels. Liquid hydrogen is expensive becuase of the effort of compressing it at low, low temperatures. I hope airbus have done their sums.
There is no doubt that the corrosion-proof alloy for the combustion chamber is critical. I hope that PHE have got this right. I was once in an outfit (ZOX) that extracted zinc from blast furnace residues at v high temperatures. That system failed because of corrosion problems at 1300C, and more of my money went down the pan....Sic gloria transit etc,.
Smartinv
Mistake; I meant q3. i am sure AGL will reply more quickly than 180 days. They surely have all info to hand now - there are masses and masses of data on Parsortix already provided to FDA, and I expect this AIR is for data that Parsortix already has but not provided, rather than something that requires more research.
Piltick
"Our process heats material in the absence of air to create accelerated decomposition of the organic matter." So to that extent it is a similar process to DMG - but they are using organic matter rather than plastic. no detail on temperatures required, throughput, efficiency etc that I could see in a quick look.
The harder question to answer - might only be answered in the long term - is, if no DTCs are found using Parsortix, what are the chances of missing DTCs in marrow? Bone marrow biopsy is not currently a routine investigation in breast cancer (as far as I know), but there might be sense in including a marrow biopsy while under GA for the primary breast procedure.
Champcharly
You are right. I was not aware of the existence of disseminated tumour cells - it seems to be a pre-metastatic cancer cell that sits around in places including bone marrow before mets develop. I would not fancy a bone marrow test, though, to find these cells, it is a distinctly unpleasant procedure. But, if disseminated tumour cells are found in marrow before CTCs appear in peripheral blood this would be an indication for earlier treatment with significant potential to imporve outcome.